India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors
Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors
M&A activity, IPOs and late-stage investments gain momentum as investors prioritize clinical validation, while early-stage biotech firms continue to face funding challenges
Through the transaction, Aurobindo USA will expand its product portfolio in this segment while gaining a U.S.-based manufacturing facility
Backs Lifesigns in first bet and doubles down on India’s healthcare AI surge
Secures high-stakes glaucoma drug in up to $2.45b bet on eye care pipeline
From a $10 billion bioeconomy to over $190 billion, indigenous CAR-T therapy, and a booming startup ecosystem highlight 12 years of transformation in India’s science and technology landscape
Evonik researchers say they have achieved a significant breakthrough with Ecobiol
The validation confirms the submission is complete, clearing the way for the EMA’s centralized review process to formally evaluate the therapy
The landmark legislation has laid the foundation for a skilled, regulated and globally competitive Allied and Healthcare Professional workforce, reshaping healthcare education and delivery across India
The company said data from multiple VESPER studies show the peptide delivered meaningful weight loss, favorable tolerability, and the possibility of a first-in-class monthly injection format
Subscribe To Our Newsletter & Stay Updated